Hypoxia promotes nuclear translocation and transcriptional function in the oncogenic tyrosine kinase RON

Hong Yi Chang, Hsiao Sheng Liu, Ming Derg Lai, Yuh Shyan Tsai, Tzong Shin Tzai, Hong Ling Cheng, Nan Haw Chow

研究成果: Article

17 引文 (Scopus)

摘要

Tumor hypoxia drives metastatic progression, drug resistance, and posttreatment relapses, but how cancer cells adapt and evolve in response to hypoxic stress is not well understood. In this study, we address this question with the discovery that the receptor tyrosine kinase RON translocates into the nucleus of hypoxic cancer cells. In response to hypoxia, nuclear RON interacts with the hypoxia-inducible factor HIF-1α in a manner that relies on RON tyrosine kinase activity, binding to the c-JUN promoter and activating it. Mechanistic investigations revealed unexpectedly that nuclear RON played a more important role in activation of the c-JUN promoter than HIF-1α, leading to increased cell proliferation, survival adaptation, in vitro migration, and tumorigenicity under hypoxic conditions. Taken together, our results pointed to a novel function for RON as a transcriptional regulator that promotes the survival of cancer cells subjected to hypoxia. These results suggest novel implications for the use of small-molecule inhibitors or monoclonal antibodies targeting the RON kinase in the prevention or treatment of advanced cancer.

原文English
頁(從 - 到)4549-4562
頁數14
期刊Cancer Research
74
發行號16
DOIs
出版狀態Published - 2014 八月 15

指紋

Protein-Tyrosine Kinases
Neoplasms
Cell Survival
Hypoxia-Inducible Factor 1
Receptor Protein-Tyrosine Kinases
Drug Resistance
rice bran saccharide
Hypoxia
Phosphotransferases
Monoclonal Antibodies
Cell Proliferation
Recurrence

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

引用此文

@article{1347e1f4ffdc4c1a8dc07074ea0028b4,
title = "Hypoxia promotes nuclear translocation and transcriptional function in the oncogenic tyrosine kinase RON",
abstract = "Tumor hypoxia drives metastatic progression, drug resistance, and posttreatment relapses, but how cancer cells adapt and evolve in response to hypoxic stress is not well understood. In this study, we address this question with the discovery that the receptor tyrosine kinase RON translocates into the nucleus of hypoxic cancer cells. In response to hypoxia, nuclear RON interacts with the hypoxia-inducible factor HIF-1α in a manner that relies on RON tyrosine kinase activity, binding to the c-JUN promoter and activating it. Mechanistic investigations revealed unexpectedly that nuclear RON played a more important role in activation of the c-JUN promoter than HIF-1α, leading to increased cell proliferation, survival adaptation, in vitro migration, and tumorigenicity under hypoxic conditions. Taken together, our results pointed to a novel function for RON as a transcriptional regulator that promotes the survival of cancer cells subjected to hypoxia. These results suggest novel implications for the use of small-molecule inhibitors or monoclonal antibodies targeting the RON kinase in the prevention or treatment of advanced cancer.",
author = "Chang, {Hong Yi} and Liu, {Hsiao Sheng} and Lai, {Ming Derg} and Tsai, {Yuh Shyan} and Tzai, {Tzong Shin} and Cheng, {Hong Ling} and Chow, {Nan Haw}",
year = "2014",
month = "8",
day = "15",
doi = "10.1158/0008-5472.CAN-13-3730",
language = "English",
volume = "74",
pages = "4549--4562",
journal = "Cancer Research",
issn = "0008-5472",
number = "16",

}

Hypoxia promotes nuclear translocation and transcriptional function in the oncogenic tyrosine kinase RON. / Chang, Hong Yi; Liu, Hsiao Sheng; Lai, Ming Derg; Tsai, Yuh Shyan; Tzai, Tzong Shin; Cheng, Hong Ling; Chow, Nan Haw.

於: Cancer Research, 卷 74, 編號 16, 15.08.2014, p. 4549-4562.

研究成果: Article

TY - JOUR

T1 - Hypoxia promotes nuclear translocation and transcriptional function in the oncogenic tyrosine kinase RON

AU - Chang, Hong Yi

AU - Liu, Hsiao Sheng

AU - Lai, Ming Derg

AU - Tsai, Yuh Shyan

AU - Tzai, Tzong Shin

AU - Cheng, Hong Ling

AU - Chow, Nan Haw

PY - 2014/8/15

Y1 - 2014/8/15

N2 - Tumor hypoxia drives metastatic progression, drug resistance, and posttreatment relapses, but how cancer cells adapt and evolve in response to hypoxic stress is not well understood. In this study, we address this question with the discovery that the receptor tyrosine kinase RON translocates into the nucleus of hypoxic cancer cells. In response to hypoxia, nuclear RON interacts with the hypoxia-inducible factor HIF-1α in a manner that relies on RON tyrosine kinase activity, binding to the c-JUN promoter and activating it. Mechanistic investigations revealed unexpectedly that nuclear RON played a more important role in activation of the c-JUN promoter than HIF-1α, leading to increased cell proliferation, survival adaptation, in vitro migration, and tumorigenicity under hypoxic conditions. Taken together, our results pointed to a novel function for RON as a transcriptional regulator that promotes the survival of cancer cells subjected to hypoxia. These results suggest novel implications for the use of small-molecule inhibitors or monoclonal antibodies targeting the RON kinase in the prevention or treatment of advanced cancer.

AB - Tumor hypoxia drives metastatic progression, drug resistance, and posttreatment relapses, but how cancer cells adapt and evolve in response to hypoxic stress is not well understood. In this study, we address this question with the discovery that the receptor tyrosine kinase RON translocates into the nucleus of hypoxic cancer cells. In response to hypoxia, nuclear RON interacts with the hypoxia-inducible factor HIF-1α in a manner that relies on RON tyrosine kinase activity, binding to the c-JUN promoter and activating it. Mechanistic investigations revealed unexpectedly that nuclear RON played a more important role in activation of the c-JUN promoter than HIF-1α, leading to increased cell proliferation, survival adaptation, in vitro migration, and tumorigenicity under hypoxic conditions. Taken together, our results pointed to a novel function for RON as a transcriptional regulator that promotes the survival of cancer cells subjected to hypoxia. These results suggest novel implications for the use of small-molecule inhibitors or monoclonal antibodies targeting the RON kinase in the prevention or treatment of advanced cancer.

UR - http://www.scopus.com/inward/record.url?scp=84905964443&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905964443&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-13-3730

DO - 10.1158/0008-5472.CAN-13-3730

M3 - Article

C2 - 24903148

AN - SCOPUS:84905964443

VL - 74

SP - 4549

EP - 4562

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 16

ER -